International Stem Cell CORP 8-K
Research Summary
AI-generated summary
International Stem Cell Corp Reports Annual Meeting Vote Results
What Happened
International Stem Cell Corporation (ISCO) filed an 8-K (Item 5.07) reporting the results of its Annual Meeting of Stockholders held on June 11, 2026. Stockholders voted on the election of four directors (per the definitive proxy statement dated April 24, 2026). All four nominees were elected to serve until the 2027 Annual Meeting.
Key Details
- Meeting date: June 11, 2026; proxy statement dated April 24, 2026.
- Directors elected by holders of Series D Preferred Stock:
- Andrey Semechkin — For: 2,457,143; Withheld: 0
- Russell Kern — For: 2,457,143; Withheld: 0
- Directors elected by holders of all shares (including preferred on an as-converted basis):
- Donald A. Wright — For: 9,288,444; Withheld: 30,590
- Paul V. Maier — For: 9,288,500; Withheld: 30,534
- Broker non-votes: none.
Why It Matters
Board elections affect company governance and strategic oversight. The filing shows the nominees won by wide margins with minimal withheld votes and no broker non-votes, indicating broad shareholder support and continuity on the board through the 2027 annual meeting.
Loading document...